Literature DB >> 6073570

An enzymatic spectrophotometric method for the determination of xanthine and hypoxanthine.

J R Klinenberg, S Goldfinger, K H Bradley, J E Seegmiller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6073570

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  14 in total

1.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

2.  Xanthinuria discovered in population screening.

Authors:  D H Curnow; J R Masarel; K J Cullen; M G McCall
Journal:  Br Med J       Date:  1971-02-13

3.  Renal urate transport during variations in urate synthesis in the rat.

Authors:  T H Steele; J L Underwood
Journal:  Pflugers Arch       Date:  1976-12-28       Impact factor: 3.657

4.  Clinical and biochemical observations on three cases of hypoxanthine-guanine phosphoribosyltransferase deficiency.

Authors:  D N Bunn; I K Moss; A Nicholls; J T Scott; M L Snaith; M R Watson
Journal:  Ann Rheum Dis       Date:  1975-06       Impact factor: 19.103

5.  Hypouricaemia and increased renal urate clearance associated with hyperparathyroidism.

Authors:  T Gibson; H P Sims; S A Jimenez
Journal:  Ann Rheum Dis       Date:  1976-08       Impact factor: 19.103

6.  Overproduction of uric acid in hypoxanthine-guanine phosphoribosyltransferase deficiency. Contribution by impaired purine salvage.

Authors:  N L Edwards; D Recker; I H Fox
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

7.  Current concepts of hyperuricemia and gout.

Authors:  J R Klinenberg
Journal:  Calif Med       Date:  1969-03

8.  Hypoxanthine-guanine phosphoribosyltransferase. Characterization of a mutant in a patient with gout.

Authors:  I H Fox; I L Dwosh; P J Marchant; S Lacroix; M R Moore; S Omura; V Wyhofsky
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

9.  Adenosine triphosphate turnover in humans. Decreased degradation during relative hyperphosphatemia.

Authors:  M A Johnson; K Tekkanat; S P Schmaltz; I H Fox
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

10.  Hyperuricemia in glycogen storage disease type I. Contributions by hypoglycemia and hyperglucagonemia to increased urate production.

Authors:  J L Cohen; A Vinik; J Faller; I H Fox
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.